Clinical Development Drugs Gene Editing Pharma Companies 
pharmaphorum
SEPTEMBER 29, 2020
As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. Case Study: From Technology Agreement to co-development and co-commercialisation partnership.
Pharmaceutical Technology
MAY 26, 2023
The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability. One big pharma company has already given the seal of approval with a successful customer quality audit.
Expert insights. Personalized for you.
132 
Let's personalize your content